Skip to main content
Premium Trial:

Request an Annual Quote

Cellink to Distribute SeqWell Single-Cell Sequencing, NGS Sample Prep Products

NEW YORK — Cellink said on Monday that it has signed an agreement to commercialize a range of SeqWell's single-cell RNA sequencing and sample preparation products outside of the US.

Under the terms of the deal, Cellink will sell in ex-US markets SeqWell's PlexWell Single-Cell Rapid Kit for plate-based single-cell RNA sequencing, which is set to launch later this month, as well as its full line of PlexWell next-generation sequencing library preparation kits.

The companies have also agreed to collaborate on new multiplex genomic assay products.

Additional terms of the deal were not disclosed.

Last month, Sweden-based Cellink signed a distribution agreement for Phasefocus' Livecyte high-content live-cell imaging platform. About a year ago, Beverly, Massachusetts-based SeqWell raised $9 million in Series B funding. 

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.